Utilisation and Safety of Deferasirox (Exjade): an Observational Cohort Study in England

Trial Profile

Utilisation and Safety of Deferasirox (Exjade): an Observational Cohort Study in England

Completed
Phase of Trial: Phase IV

Latest Information Update: 10 Oct 2017

At a glance

  • Drugs Deferasirox (Primary)
  • Indications Iron overload; Myelodysplastic syndromes; Thalassaemia
  • Focus Adverse reactions
  • Most Recent Events

    • 10 Oct 2017 Results published in the Drug Safety
    • 30 Aug 2017 Results evaluating safety and utilization of Deferasirox in older adults, presented at the 33rd International Conference on Pharmacoepidemiology and Therapeutic Risk Management
    • 06 Oct 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top